Lawson Products, Inc. (LAWS)
(Delayed Data from NSDQ)
$32.98 USD
+0.29 (0.89%)
Updated May 3, 2019 04:00 PM ET
After-Market: $32.63 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$32.98 USD
+0.29 (0.89%)
Updated May 3, 2019 04:00 PM ET
After-Market: $32.63 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
TriMas (TRS) Rides on Strong Product Pipeline, Costs High
by Zacks Equity Research
Despite weak demand in many of its end markets, TriMas (TRS) is poised well on its pricing actions and ongoing TriMas Business Model, which is aimed at improving management and business performance.
O-I Glass (OI) Surges: Stock Moves 5.5% Higher
by Zacks Equity Research
O-I Glass (OI) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Lawson Products (LAWS) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Lawson Products (LAWS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Silgan (SLGN) Q3 Earnings & Sales In Line with Estimates
by Zacks Equity Research
Silgan's (SLGN) third-quarter top and bottom line matched the Zacks Consensus Estimate and the company cut adjusted earnings per share to the range of $2.12 to $2.17.
Packaging Corp (PKG) Q3 Earnings Beat Estimates, Sales Miss
by Zacks Equity Research
Packaging Corporation (PKG) Q3 earnings beat the Zacks Consensus Estimate but was lower than the year-ago quarter due to higher costs and lower volume in the Paper and Packaging segments.
Lawson Products (LAWS) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Lawson Products (LAWS) delivered earnings and revenue surprises of 40.82% and 1.51%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Lawson Products (LAWS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Lawson Products (LAWS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Lawson Products (LAWS) Beats Q2 Earnings Estimates and Revenue Estimates
by Zacks Equity Research
Lawson Products (LAWS) delivered earnings and revenue surprises of 26.53% and 0.86%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Lawson Products (LAWS) Lags Q2 Earnings Estimates
by Zacks Equity Research
Lawson Products (LAWS) delivered earnings and revenue surprises of -71.43% and 0.86%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Lawson Products (LAWS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Lawson Products (LAWS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Lawson Products Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Lawson Products has been struggling lately, but the selling pressure may be coming to an end soon.
Silgan (SLGN) Rides on Acquisitions, Material Costs High
by Zacks Equity Research
Since its inception, Silgan Holdings (SLGN) has acquired 35 businesses and improved market share in each of its segments.
Greif (GEF) Rides on Caraustar Acquisition Amid Debt Burdens
by Zacks Equity Research
The Caraustar buyout strengthens Greif's (GEF) leadership in industrial packaging as well as significantly bolsters its margins, free cash flow and profitability.
Caterpillar's May Sales Growth of 6% Hits Year's Lowest Point
by Zacks Equity Research
Caterpillar's (CAT) global machine sales growth rate chart has been in the single digits so far this year, at levels last witnessed in 2017.
Lindsay Banks on Infrastructure Business Amid Higher Costs
by Zacks Equity Research
Lindsay (LNN) remains focused on simplifying its business in order to improve productivity in the wake of weak agricultural demand.
Dover's (DOV) DFS Introduces Advanced Fuel Dispenser Series
by Zacks Equity Research
Dover's (DOV) DFS's Tokheim Quantium 510M provides more model options and features to customers with an enriched dispenser head.
AGCO Corp Stock Rallies 29% YTD: What's Working in Favor?
by Zacks Equity Research
Forecast-topping earnings performance during the March-end quarter and an upbeat outlook contribute to the run-up in AGCO Corp's (AGCO) shares.
Here's Why TriMas Stock is an Attractive Investment Option
by Zacks Equity Research
Apart from forecast topping earnings, strong demand, product pipeline let's have a look at some other factors that make TriMas (TRS) a compelling choice at the moment.
Milacron Plunges 38% in a Year: What's Ailing the Stock?
by Zacks Equity Research
Milacron Holdings (MCRN) intends to mitigate the tariffs-related headwinds by focusing on pricing actions, negotiations with existing vendors and making supply chain modifications.
Here's Why You Should Hold Deere Stock in Your Portfolio Now
by Zacks Equity Research
With solid equipment demand, focus on the Wirtgen acquisition and long-term opportunities, Deere (DE) is worth retaining in the portfolio at the moment.
AptarGroup Acquires 2 Companies to Expand Pharma Services
by Zacks Equity Research
The acquisitions of Nanopharm and Gateway Analytical aid AptarGroup's (ATR) pharma to support customers' complex drug formulations and delivery requirements.
Avery Dennison Shares Up 26% YTD: What's Driving the Rally?
by Zacks Equity Research
Forecast-topping earnings performance during the January-March period and upbeat outlook for 2019 contribute to the run-up in Avery Dennison's (AVY) shares.
Ball Corp Attains New 52-Week: What's Driving the Rally?
by Zacks Equity Research
Solid demand for aluminum packaging and robust aerospace backlog will drive Ball Corporation's (BLL) results.
AptarGroup (ATR) Hits 52-Week High: What's Driving the Rally?
by Zacks Equity Research
Forecast-topping first-quarter 2019 results and encouraging growth projections are contributing to the rally in AptarGroup's (ATR) shares.
Manitowoc Rides on Strong Order Flow & Product Innovation
by Zacks Equity Research
Manitowoc (MTW) well poised to gain from order strength in the United States and pricing actions.